サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1722788

OTC薬の市場規模、シェア、動向、予測：製品タイプ、投与経路、剤形、流通チャネル、地域別、2025年～2033年

Over The Counter (OTC) Drugs Market Size, Share, Trends and Forecast by Product Type, Route of Administration, Dosage Form, Distribution Channel, and Region, 2025-2033

出版日
発行
IMARC
ページ情報
英文 140 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
OTC薬の市場規模、シェア、動向、予測：製品タイプ、投与経路、剤形、流通チャネル、地域別、2025年～2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

OTC薬の世界市場規模は2024年に1,780億米ドルとなりました。今後、IMARC Groupは、同市場が2033年には2,882億9,000万米ドルに達し、2025年から2033年にかけて5.23％のCAGRを示すと予測しています。2024年のOTC薬市場シェアは、現在北米が42.2％で圧倒的です。同地域の市場を牽引しているのは、セルフメディケーションに対する消費者の強い嗜好、高いヘルスケア支出、小売店の普及、非処方薬に対する規制当局の好意的な支援です。

非処方薬として知られるOTC薬は、処方箋がなくても使用でき、ヘルスケア専門家による治療を受ける必要もないです。これらは安全で効果的であり、疼痛、咳や風邪、下痢、便秘、にきびを治し、繰り返し起こる偏頭痛やアレルギーの管理に役立ちます。現在、世界中の薬局、コンビニエンスストア、スーパーマーケット、ガソリンスタンドで販売されています。

OTC薬市場動向：

個人の間で軽度の病気の治療にOTC薬の利用が増加していることは、市場の成長を後押しする重要な要因の一つです。これに加えて、制酸剤、ヒスタミン-2（H2）遮断剤、プロトンポンプ阻害剤（PPI）などのOTC医薬品は、胸焼けや酸欠の緩和や予防に使用されています。さらに、コロナウイルス感染症（COVID-19）の流行により、セルフケアの重要性に対する個人の意識が高まっています。その結果、栄養補助食品の売上が増加し、市場の成長が強化されています。さらに、主要企業は消費者層を拡大し、地理的プレゼンスを高めるために製品ポートフォリオを拡大しています。このことは、処方薬をOTC薬に切り替えるための規制機関からの承認の増加と相まって、市場にプラスの影響を与えています。これとは別に、現在、ヘルスケアコストの増加を理由に、医師に相談せずにOTC医薬品を選ぶ人が増えています。さらに、セルフメディケーションの実践は、慢性疾患のコントロール、欠勤の減少、軽症時の医療資源の節約に役立ちます。その他、世界の老人人口の増加、流通チャネルの急速な拡大、製薬業界の著しい成長などが、全体的な売上高と収益性を押し上げています。

本レポートで扱う主な質問

  • OTC薬市場の規模は？
  • OTC薬市場の将来展望は？
  • OTC薬市場を牽引する主要因は何か？
  • OTC薬市場で最大のシェアを占める地域は？
  • 世界のOTC薬市場における主要企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のOTC薬市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 咳、風邪、インフルエンザ対策製品
  • 鎮痛剤
  • 皮膚科製品
  • 胃腸薬
  • ビタミン、ミネラル、サプリメント（VMS）
  • 減量/ダイエット製品
  • 眼科用製品
  • 睡眠補助剤
  • その他

第7章 市場内訳：投与経路別

  • 経口
  • 非経口
  • 外用
  • その他

第8章 市場内訳：剤形別

  • 錠剤とカプセル
  • 液体
  • 軟膏
  • その他

第9章 市場内訳：流通チャネル別

  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Alkem Laboratories Limited
    • Bayer AG
    • Daiichi Sankyo Company Limited
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Novartis AG
    • Perrigo Company plc
    • Pfizer Inc.
    • Piramal Enterprises Ltd.
    • Reckitt Benckiser Group PLC
    • Sanofi S.A.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
図表

List of Figures

  • Figure 1: Global: Over The Counter Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Over The Counter Drugs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Over The Counter Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Over The Counter Drugs Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Over The Counter Drugs Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Over The Counter Drugs Market: Breakup by Dosage Form (in %), 2024
  • Figure 7: Global: Over The Counter Drugs Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Over The Counter Drugs Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Over The Counter Drugs (Analgesics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Over The Counter Drugs (Analgesics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Over The Counter Drugs (Dermatology Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Over The Counter Drugs (Dermatology Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Over The Counter Drugs (Gastrointestinal Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Over The Counter Drugs (Gastrointestinal Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Over The Counter Drugs (Ophthalmic Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Over The Counter Drugs (Ophthalmic Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Over The Counter Drugs (Sleeping Aids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Over The Counter Drugs (Sleeping Aids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Over The Counter Drugs (Other Product Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Over The Counter Drugs (Other Product Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Over The Counter Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Over The Counter Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Over The Counter Drugs (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Over The Counter Drugs (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Over The Counter Drugs (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Over The Counter Drugs (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Over The Counter Drugs (Other Route of Administrations) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Over The Counter Drugs (Other Route of Administrations) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Over The Counter Drugs (Tablets and Capsules) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Over The Counter Drugs (Tablets and Capsules) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Over The Counter Drugs (Liquids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Over The Counter Drugs (Liquids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Over The Counter Drugs (Ointments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Over The Counter Drugs (Ointments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Over The Counter Drugs (Other Dosage Forms) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Over The Counter Drugs (Other Dosage Forms) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: Over The Counter Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: Over The Counter Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Global: Over The Counter Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Global: Over The Counter Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Global: Over The Counter Drugs (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Global: Over The Counter Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Global: Over The Counter Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Global: Over The Counter Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: North America: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: North America: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: United States: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: United States: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Canada: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Canada: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Asia-Pacific: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Asia-Pacific: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: China: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: China: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Japan: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Japan: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: India: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: India: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: South Korea: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: South Korea: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Australia: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Australia: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Indonesia: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Indonesia: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Europe: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Europe: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Germany: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Germany: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: France: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: France: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: United Kingdom: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: United Kingdom: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Italy: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Italy: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Spain: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Spain: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Russia: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Russia: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Others: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Latin America: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Latin America: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Brazil: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Brazil: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Mexico: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 94: Mexico: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 95: Others: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 96: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 97: Middle East and Africa: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 98: Middle East and Africa: Over The Counter Drugs Market: Breakup by Country (in %), 2024
  • Figure 99: Middle East and Africa: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 100: Global: Over The Counter Drugs Industry: SWOT Analysis
  • Figure 101: Global: Over The Counter Drugs Industry: Value Chain Analysis
  • Figure 102: Global: Over The Counter Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Over The Counter Drugs Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Over The Counter Drugs Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Over The Counter Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Over The Counter Drugs Market Forecast: Breakup by Dosage Form (in Million USD), 2025-2033
  • Table 5: Global: Over The Counter Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Over The Counter Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Over The Counter Drugs Market: Competitive Structure
  • Table 8: Global: Over The Counter Drugs Market: Key Players
目次
Product Code: SR112025A5189

The global over the counter (OTC) drugs market size was valued at USD 178.00 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 288.29 Billion by 2033, exhibiting a CAGR of 5.23% from 2025-2033. North America currently dominates the over the counter (OTC) drugs market share at 42.2% in 2024. The market in the region is driven by strong consumer preference for self-medication, high healthcare expenditures, widespread retail availability, and favorable regulatory support for non-prescription medications.

Over the counter (OTC) drugs, also known as non-prescription drugs, can be used without a prescription or the need for seeking treatment by a healthcare professional. They are safe and effective and help cure pain, cough and cold, diarrhea, constipation, acne and manage recurring migraines and allergies. They are currently available in pharmacies, convenience stores, supermarkets and gas stations across the globe.

Over The Counter (OTC) Drugs Market Trends:

The increasing utilization of OTC drugs to treat minor ailments among individuals represents one of the key factors bolstering the market growth. Besides this, OTC medications, such as antacids, histamine-2 (H2) blockers, and proton pump inhibitors (PPIs), are used to relieve and prevent heartburn or acid indigestion. In addition, due to the coronavirus disease (COVID-19) outbreak, there is a rise in awareness among individuals about the importance of self-care. This, in turn, is increasing the sales of nutritional supplements and strengthening the market growth. Moreover, key players are expanding their product portfolio to widen their consumer base and increase their geographical presence. This, coupled with the increasing approvals from regulatory bodies for switching prescription drugs to OTC drugs, is positively influencing the market. Apart from this, there is currently an increase in the number of people opting for OTC drugs rather than consulting physicians on account of increasing healthcare costs. Furthermore, self-medication practices can assist in controlling chronic diseases, reducing absenteeism from work, and saving scarce medical resources from being exhausted during minor conditions. Some of the other factors, such as the rising geriatric population worldwide, rapid expansion of distribution channels, and significant growth in the pharmaceutical industry, are driving the overall sales and profitability.

Key Market Segmentation:

Breakup by Product Type:

  • Cough, Cold and Flu Products
  • Analgesics
  • Dermatology Products
  • Gastrointestinal Products
  • Vitamins, Minerals and Supplements (VMS)
  • Weight-loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Others

Breakup by Route of Administration:

  • Oral
  • Parenteral
  • Topical
  • Others

Breakup by Dosage Form:

  • Tablets and Capsules
  • Liquids
  • Ointments
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Alkem Laboratories Limited, Bayer AG, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1.How big is the over the counter (OTC) drugs market?
  • 2.What is the future outlook of the over the counter (OTC) drugs market?
  • 3.What are the key factors driving the over the counter (OTC) drugs market?
  • 4.Which region accounts for the largest over the counter (OTC) drugs market share?
  • 5.Which are the leading companies in the global over the counter (OTC) drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Over The Counter (OTC) Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Cough, Cold and Flu Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Analgesics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dermatology Products
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Gastrointestinal Products
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Vitamins, Minerals and Supplements (VMS)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Weight-loss/Dietary Products
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Ophthalmic Products
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Sleeping Aids
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9 Others
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Topical
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Dosage Form

  • 8.1 Tablets and Capsules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Liquids
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ointments
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Alkem Laboratories Limited
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Daiichi Sankyo Company Limited
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Dr. Reddy's Laboratories Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 GlaxoSmithKline plc
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Novartis AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Perrigo Company plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Piramal Enterprises Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Reckitt Benckiser Group PLC
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Sanofi S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Sun Pharmaceutical Industries Ltd.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Teva Pharmaceutical Industries Ltd.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis